Carson Wealth (CWM LLC)’s Ascendis Pharma A/S ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$308K Sell
1,347
-48
-3% -$10.8K ﹤0.01% 2363
2025
Q4
$297K Buy
1,395
+1,391
+34,775% +$287K ﹤0.01% 2263
2025
Q3
$1K Buy
+4
New +$746 ﹤0.01% 5075
2022
Q2
Sell
-27
Closed -$3K 3765
2022
Q1
$3K Buy
+27
New +$3.13K ﹤0.01% 2999

Other funds holding ASND

Carson Wealth (CWM LLC)'s ASND Position: Q1 2026 in Review

Carson Wealth (CWM LLC) reduced its Ascendis Pharma A/S (ASND) stake by 3.4% in Q1 2026, selling an estimated $10.8K and leaving 1,347 shares worth $308K. The position accounts for ﹤0.01% of the portfolio, ranked #2363.

Carson Wealth (CWM LLC) first reported a position in ASND in Q1 2022 and has held it in 4 quarters since. 273 funds tracked by Wall St. Rank hold ASND as of Q1 2026.

  • Carson Wealth (CWM LLC) held 1,347 shares of Ascendis Pharma A/S worth $308K as of Q1 2026.
  • Carson Wealth (CWM LLC) sold 48 Ascendis Pharma A/S shares in Q1 2026, an estimated $10.8K.
  • Ascendis Pharma A/S made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #2363 holding.
  • Carson Wealth (CWM LLC) first reported a position in Ascendis Pharma A/S in Q1 2022 and has held it in 4 quarters since.
  • 273 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.